Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
C8 Sciences
AddedFeb 15, 2024
UpdatedJun 18, 2026
C8 Sciences

C8 Sciences

Angel

C8 Sciences: Enhancing learning through neuroscience-based cognition programs, specializing in ADHD.

HQ
New Haven, CT, US
Founded
2011
Overview
Compare
Fundraising
Employees
Website

C8 Sciences, founded with a mission to enhance learning through neuroscience-based cognition programs, focuses on improving the Eight Core Cognitive Capacities essential for learning. Their flagship product, C8Kids, targets early assessment and intervention for children with learning difficulties such as ADHD. The company leverages a combination of neuroscience and video game technology to create engaging and effective cognitive development tools.

Notable figures associated with C8 Sciences include experts in neuroscience and education, though specific names are not provided. The company has achieved significant milestones in the field of cognitive development, particularly in addressing ADHD in children. Their innovative approach has made a substantial impact on educational methodologies and mental health strategies, contributing to improved learning outcomes and emotional well-being across various age groups.

C8 Sciences - Similar Companies

Stronger Brains logo

Stronger Brains

strongerbrains.com

Reflection Sciences logo

Reflection Sciences

CogniFit logo

CogniFit

cognifit.com

Sheepdog Sciences logo

Sheepdog Sciences

BrainLeap Technologies logo

BrainLeap Technologies

brainleaptech.com

Posit Science logo

Posit Science

brainhq.com

Blank Slate Technologies logo

Blank Slate Technologies

blankslatetech.co

Oyalabs logo

Oyalabs

NeuroCog Trials logo

NeuroCog Trials

NeuroTrainer logo

NeuroTrainer

neurotrainer.com

Childnexus logo

Childnexus

childnexus.com

Neurotrack logo

Neurotrack

neurotrack.com

Cognigenics logo

Cognigenics

8D World logo

8D World

Cognitive Arts logo

Cognitive Arts

C8 Sciences - Quick Facts

Who are C8 Sciences' competitors?

Companies similar to C8 Sciences include Stronger Brains, Reflection Sciences, CogniFit and Sheepdog Sciences.

When was C8 Sciences founded?

C8 Sciences was founded in 2011.

Where is C8 Sciences' headquarters located?

C8 Sciences' headquarters is located in New Haven, CT, US.

When was C8 Sciences' last funding round?

C8 Sciences' most recent funding round was for $320k (USD) in June 2012.

How much has C8 Sciences raised to-date?

As of Jun 12, 2012, C8 Sciences has raised a total of $320k (USD).

How many employees does C8 Sciences have?

C8 Sciences has 11 employees as of Feb 4, 2024.

C8 Sciences - Classification

Ownership
  • Private
Technology
  • AI
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Education
Main Product
  • Cognitive Development
Tags
  • Healthtech
NAICS
  • 610000Educational Services
  • 611000Educational Services
SIC
  • 8200Educational Services
  • 8290Schools And Educational Services, Not Elsewhere Classified